INBODY CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28,400 KRW | -4.54% |
|
-2.91% | +12.03% |
| 2023 | InBody Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | InBody Releases BPBIO 220 and BPBIO 250 | CI |
Evolution of the average Target Price on InBody Co.,Ltd
Price target over the last 5 years
History of analyst recommendation changes
b43d0e9b0403cc3c.7wD6-GqsjLz2V4JRpnnRxdnN5uC7qAGzATqdOnHLXXU.omaSgSWe5_SjO88yzCyQj5SGsY6DxnXrRFHYbDanPAyib9e1JuXfjKQb7Q~f8a1dec44f18c12f79ae2b9fe32f9764
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
28,400
KRW
Average target price
38,000
KRW
Spread / Average Target
+33.80%
High Price Target
39,000
KRW
Spread / Highest target
+37.32%
Low Price Target
37,000
KRW
Spread / Lowest Target
+30.28%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A041830 Stock
- Consensus InBody Co.,Ltd